Steven T. Reed, O.D., President of the American Optometric Association, discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults over 50, and the importance of early diagnosis and preventive care.
The study, published in The Lancet Digital Health, found that deep learning tech had an average accuracy of 88% when it came to diagnosing genetic syndromes.
Ute Deichmann of the Jacques Loeb Centre for the History and Philosophy of the Life Sciences at Ben-Gurion University, explores the role hierarchical causal models have on constancy and plasticity in biology.
A study, published in the journal DNA Repair, finds that hydroxychloroquine (HCQ) is potentially toxic to mammals - the drug that was previously elevated to the status of miracle COVID cure in some circles.
Dr Jen Vanderhoven, Director, National Horizons Centre, Teesside University, sheds some light on how the gene therapy field can progress in the face of funding challenges and skills shortages.
A team at Newcastle University have identified a gene, HLA-DRB1*04:01, which could be responsible for individuals who are asymptomatic - suggesting that the gene offers some protection against severe COVID.
Graham Brookes, Agricultural Economist with PG Economics, UK, charts how the development and deployment of COVID-19 vaccines, derived using techniques of genetic modification, highlight ideological inconsistency and hypocrisy.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, provides a portrait of a ground-breaking technology, next-generation sequencing, starting with a brief snapshot.
The idea is still at an early stage, but initial clinical study results show that immunotherapy against type 1 diabetes could function as a 'diabetes vaccine.'
Three academic experts, including Richard E. Goodman from the Food Allergy Research and Resource Program, shed light on defeating late blight disease of potato in sub-Saharan Africa, starting with a brief introduction to the crop in question.
Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.
Richie Kohman, Synthetic Biology Platform Lead at Wyss Institute at Harvard, explains the use of next-generation sequencing to analyse biological tissues in a spatially resolved context.
